Inactive Instrument

News Parnell Pharmaceuticals Holdings Ltd Other OTC

Equities

PARNF

AU0000XINEU9

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Parnell Pharmaceuticals : Welcomes Dr. Chelsie Estey as Vice President of U.S. Pet Care	03-07	PU
Parnell Pharmaceuticals : Adds Three Experts to Leadership Team	30/05/23	PU
Parnell Pharmaceuticals : Two New Territory Business Managers Help Parnell Better Serve Producers and Veterinarians	30/05/23	PU
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering	06/01/23	PR
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering	06/12/22	PR
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum	21/06/22	AQ
Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	20/06/22	CI
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners completed the acquisition of a 29% stake in Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $2.5 million	27/01/21	CI
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners made an offer to acquire Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $7.2 million.	20/12/20	CI
Parnell Pharmaceuticals Announces Nomovid Antiviral Nasal Spray	23/09/20	CI
Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	13/10/19	CI
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Full Year Ended 31 December 2018; Provides Earnings Guidance for the Year 2019	04/04/19	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2018; Revises Revenue Guidance for the Year 2018	02/11/18	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018; Revised Earnings Guidance for the Full Year 2018	03/08/18	CI
Parnell Pharmaceuticals Holdings Ltd Reports Audited Earnings Results for the First Quarter Ended March 31, 2018; Revises Earnings Guidance for the Year 2018	28/04/18	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Earnings Guidance for the Year 2017	17/08/17	CI
Certain Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	29/03/17	CI
Certain Options of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	29/03/17	CI
Certain Warrants of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	29/03/17	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Consolidated Earnings Results for the Year Ended December 31, 2016; Provides Earnings Guidance for the Year 2017	21/03/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Parnell Pharmaceuticals Holdings Ltd Other OTC

Equities

PARNF

AU0000XINEU9

Summary

Filters